Key | % Net Assets |
---|---|
BP | 7.1% |
Vodafone Group | 5.2% |
GlaxoSmithKline | 4.6% |
Royal Dutch Shell A | 4.5% |
Other | 78.6% |
Name | % Net Assets |
---|---|
BP | 7.1% |
Vodafone Group | 5.2% |
GlaxoSmithKline | 4.6% |
Royal Dutch Shell A | 4.5% |
HSBC Holdings LC (UK Reg) | 3.9% |
Royal Dutch Shell B | 3.3% |
Astrazeneca | 2.9% |
Bg Group | 2.9% |
British American Tobacco | 2.6% |
BHP Billiton | 2.5% |
No asset data available.
Date | 08-Jan-2021 |
---|---|
NAV | 624.30p |
Currency | GBP |
Change | 1.60p |
% | 0.26% |
YTD change | 624.30p |
YTD % | n/a |
Fund Inception | 26/03/1990 |
---|---|
Fund Manager | Sinopia Asset Management (UK) Ltd |
TER | 0.27 (15-Nov-2011) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £1,000,000 |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.25% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.10 |
You are here: research